Erratum: Embryonic epithelial Pten deletion through Nkx2.1-cre leads to thyroid tumorigenesis in a strain-dependent manner (Endocrine-Related Cancer 19 (111-122) DOI:10.1530/ERC-10-0327);Embryonic epithelial Pten deletion through Nkx2.1-cre leads to thyroid tumorigenesis in a strain-dependent manner

Endocrine-Related Cancer

Volumn 19, Issue 2, 2012, Pages 111-122

  Tiozzo, Caterina ^a,b,c   Danopoulos, Soula ^a   Lavarreda Pearce, Maria ^a   Baptista, Sheryl ^a   Varimezova, Radka ^a   Al Alam, Denise ^a   Warburton, David ^a   Virender, Rehan ^d   De Langhe, Stijn ^e   Di Cristofano, Antonio ^f   Bellusci, Saverio ^a,g   Minoo, Parviz ^a,b,h  

^a CHILDREN S HOSPITAL LOS ANGELES   (United States)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^c NASSAU UNIVERSITY MEDICAL CENTER   (United States)

^d HARBOR UCLA MEDICAL CENTER   (United States)

^e DEPARTMENT OF MEDICINE   (United States)

^f ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^g JUSTUS LIEBIG UNIVERSITY GIESSEN   (Germany)

^h WOMEN S AND CHILDREN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; THYROTROPIN; THYROXINE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BAGG ALBINO MOUSE; C57BL 6 MOUSE; CARCINOGENESIS; CELL DEGENERATION; CELL DIFFERENTIATION; CONTROLLED STUDY; EMBRYO; GENE DELETION; GENE MUTATION; GENOTYPING TECHNIQUE; HOMOZYGOSITY; HORMONE DETERMINATION; HYPERPLASIA; HYPOTHYROIDISM; IMMUNOHISTOCHEMISTRY; MOUSE; MOUSE MUTANT; MOUSE STRAIN; NONHUMAN; SURVIVAL; THYROID CANCER; THYROID CELL; THYROID EPITHELIUM; THYROID FOLLICLE CELL; TRANSGENIC MOUSE;

EID: 84860909272     PISSN: 13510088     EISSN: 14796821     Source Type: Journal    
DOI: 10.1530/ERC-10-0327e     Document Type: Erratum

References (23)

1. Antico-Arciuch VG, Dima M, Liao XH, Refetoff S & Di Cristofano A 2010 Cross-talk between PI3K and estrogen in the mouse thyroid predisposes to the development of follicular carcinomas with a higher incidence in females. Oncogene 29 5678-5686. (doi:10.1038/onc.2010.308)
2. Brabant G, Maenhaut C, Köhrle J, Scheumann G, Dralle H, Hoang-Vu C, Hesch RD, von zur Mühlen A, Vassart G & Dumont JE 1991 Human thyrotropin receptor gene: expression in thyroid tumors and correlation to markers of thyroid differentiation and dedifferentiation. Molecular and Cellular Endocrinology 82 R7-12. (doi:10.1016/0303-7207(91)90018-N)
3. Coulonval K, Vandeput F, Stein RC, Kozma SC, Lamy F & Dumont JE 2000 Phosphatidylinositol 3-kinase, protein kinase B and ribosomal S6 kinases in the stimulation of thyroid epithelial cell proliferation by cAMP and growth factors in the presence of insulin. Biochemical Journal 348 (Pt 2) 351-358. (doi:10.1042/0264-6021:3480351)
4. Dumont JE, Lamy F, Roger P & Maenhaut C 1992 Physiological and pathological regulation of thyroid cell proliferation and differentiation by thyrotropin and other factors. Physiological Reviews 72 667-697.
5. Eng C 1998 Genetics of Cowden syndrome: through the looking glass of oncology. International Journal of Oncology 12 701-710. (Pubitemid 28097303)
6. Ezzat S, Sarti DA, Cain DR & Braunstein GD 1994 Thyroid incidentalomas. Prevalence by palpation and ultrasonography. Archives of Internal Medicine 154 1838-1840. (doi:10.1001/archinte.1994.00420160075010)
7. Freeman D, Lesche R, Kertesz N, Wang S, Li G, Gao J, Groszer M, Martinez-Diaz H, Rozengurt N, Thomas G et al. 2006 Genetic background controls tumor development in PTEN-deficient mice. Cancer Research 66 6492-6496. (doi:10.1158/0008-5472.CAN-05-4143)
8. van der Kallen CJ, Spierings DC, Thijssen JH, Blankenstein MA & de Bruin TW 1996 Disrupted co-ordination of Pax-8 and thyroid transcription factor-1 gene expression in a dedifferentiated rat thyroid tumour cell line derived from FRTL-5. Journal of Endocrinology 150 377-382. (doi:10.1677/joe.0. 1500377)
9. Kimura T, Van Keymeulen A, Golstein J, Fusco A, Dumont JE & Roger PP 2001 Regulation of thyroid cell proliferation by TSH and other factors: a critical evaluation of in vitro models. Endocrine Reviews 22 631-656. (doi:10.1210/er.22.5.631)
10. Kusakabe T, Kawaguchi A, Kawaguchi R, Feigenbaum L & Kimura S 2004 Thyrocyte-specific expression of cre recombinase in transgenic mice. Genesis 39 212-216. (doi:10.1002/gene.20043)
11. Lazar V, Bidart JM, Caillou B, Mahé C, Lacroix L, Filetti S & Schlumberger M 1999 Expression of the NaC/IK symporter gene in human thyroid tumors: a comparison study with other thyroid-specific genes. Journal of Clinical Endocrinology and Metabolism 84 3228-3234. (doi:10.1210/jc.84.9.3228)
12. Lesche R, Groszer M, Gao J, Wang Y, Messing A, Sun H, Liu X & Wu H 2002 Cre/loxP-mediated inactivation of the murine Pten tumor suppressor gene. Genesis 32 148-149. (doi:10.1002/gene.10036)
13. Longy M & Lacombe D 1996 Cowden disease. Report of a family and review. Annales de Génétique 39 35-42. (Pubitemid 26143482)
14. Mansouri A, Chowdhury K & Gruss P 1998 Follicular cells of the thyroid gland require Pax8 gene function. Nature Genetics 19 87-90. (doi:10.1038/ng0598-87)
15. Nelen MR, van Staveren WC, Peeters EA, Hassel MB, Gorlin RJ, Hamm H, Lindboe CF, Fryns JP, Sijmons RH, Woods DG et al. 1997 Germline mutations in the PTEN/MMAC1 gene in patients with Cowden disease. Human Molecular Genetics 6 1383-1387. (doi:10.1093/hmg/6.8.1383)
16. Pan Q, Li C, Xiao J, Kimura S, Rubenstein J, Puelles L & Minoo P 2004 In vivo characterization of the Nkx2.1 promoter/enhancer elements in transgenic mice. Gene 331 73-82. (doi:10.1016/j.gene.2004.01.026)
17. Ringel MD, Hayre N, Saito J, Saunier B, Schuppert F, Burch H, Bernet V, Burman KD, Kohn LD & Saji M 2001 Overexpression and overactivation of Akt in thyroid carcinoma. Cancer Research 61 6105-6111. (Pubitemid 32762546)
18. Rivas M & Santisteban P 2003 TSH-activated signaling pathways in thyroid tumorigenesis. Molecular and Cellular Endocrinology 213 31-45. (doi:10.1016/j.mce.2003.10.029)
19. Scala S, Bruni P, Lo Muzio L, Mignogna M, Viglietto G & Fusco A 1998 Novel mutation of the PTEN gene in an Italian Cowden's disease kindred. International Journal of Oncology 13 665-668. (Pubitemid 28435340)
20. Tiozzo C, De Langhe S, Yu M, Londhe VA, Carraro G, Li M, Li C, Xing Y, Anderson S, Borok Z et al. 2009 Deletion of Pten expands lung epithelial progenitor pools and confers resistance to airway injury. American Journal of Respiratory and Critical Care Medicine 180 701-712. (doi:10.1164/rccm.200901- 0100OC)
21. Xu Q, Tam M & Anderson SA 2008 Fate mapping Nkx2.1-lineage cells in the mouse telencephalon. Journal of Comparative Neurology 506 16-29. (doi:10.1002/cne.21529)
22. Yeager N, Klein-Szanto A, Kimura S & Di Cristofano A 2007 Pten loss in the mouse thyroid causes goiter and follicular adenomas: insights into thyroid function and Cowden disease pathogenesis. Cancer Research 67 959-966. (doi:10.1158/0008-5472.CAN-06-3524)
23. Zhang P, Zuo H, Ozaki T, Nakagomi N & Kakudo K 2006 Cancer stem cell hypothesis in thyroid cancer. Pathology International 56 485-489. (doi:10.1111/j.1440-1827.2006.01995.x)